Your session is about to expire
← Back to Search
Lifestyle Intervention with Coaching for Cognitive Impairment (PREVENTION Trial)
PREVENTION Trial Summary
This trial is a 12-month, two-arm randomized clinical trial (RCT) in adults 50-80 years old experiencing cognitive decline. The objective is to evaluate the efficacy of a coached, data-driven, multi-modal lifestyle intervention to treat cognitive decline.
PREVENTION Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPREVENTION Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PREVENTION Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My gender, race, or ethnicity does not limit my participation.I have a caregiver or legal representative to accompany me for my treatments.I can use a mobile phone, iPad, or computer as confirmed by staff.You have a high score on a test for dementia.My health conditions are stable, and I haven't started new meds for them in the last 3 months.I am between 50 and 80 years old.I or my immediate family have a high-risk gene mutation for Alzheimer's.My doctor says I can do moderate exercise.You should have normal eyesight or corrected eyesight and normal color vision based on your own report.My functional status is moderately affected by my condition.I have been diagnosed with a neurodegenerative disorder that is not Alzheimer's.I am willing to have an amyloid PET scan or share my positive amyloid PET scan results.If you score below 20 on a test called the Mini Mental State Exam (MMSE), you may not be able to join the study.My cognitive issues are mainly due to a cerebrovascular disease.
- Group 1: Group 1 - Data-driven clinical recommendations (CR)
- Group 2: Group 2 - Data-driven coached multi-modal intervention (MMIC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still availability for individuals to join this medical experiment?
"Accurate. According to the data on clinicaltrials.gov, this research study began recruiting participants on July 12th 2019 and is still actively searching for candidates as of June 11th 2022. Sixty people need to be recruited from a single location."
How many individuals can partake in this clinical experiment?
"Correct. Clinicaltrials.gov documents show that this experiment, first uploaded on July 12th 2019, is actively seeking volunteers. Approximately 60 individuals are desired from a single facility for the trial's duration."
Who has the aptitude to partake in this scientific experiment?
"This research is looking to recruit 60 Alzheimer's disease patients between the ages of 50-80 that meet a specific set of criteria. These include: neurological and physical evaluations confirming no abnormal signs, an MMSE score greater than 19, stability on current medications for three months prior, ability to communicate with coaches telephonically or through video calls, having a caregiver/representative for those in FAST Stage 4, eligible regardless of gender/race/ethnicity have a FAST stage from 2-4 and be able to access computers and web interfaces either independently or with available help."
Is there an age limit when it comes to participating in this research?
"According to the established parameters, potential participants must be between 50 and 80 years old."
Share this study with friends
Copy Link
Messenger